It is Mark Cuban Cost Plus Drug Company's first collaboration with a health plan. The pharmacy company will not be replacing Capital Blue Cross' existing pharmacy benefits manger, but instead will be an additional option for members to choose.
Oh to be a healthcare startup with billionaire investors fighting for a piece of your business. That's the situation in which DNAsimple CEO and founder Olivier Noel found himself when Mark Cuban and Richard Branson made competing offers to the entrepreneur on Shark Tank.
After a few months of home treatment with the Samsung VR set, Cuban reported that he's back to "normal and happy." He only needs to put the goggles on once every couple of weeks, just for the sake of maintenance.
Robert Gentleman, Genentech's former senior director of bioinformatics, has taken on a position with 23andMe in the role of vice president of computational biology.
Johns Hopkins has been sued for $1 billion for playing "a key role in a government study of syphilis and other sexually transmitted diseases in Guatemala." Mark Cuban goes toe-to-toe with some of healthcare's intelligentsia (who wins?). Read these items and more in the Morning Read.
Mark Cuban has been all over SXSW (we've had our own coverage). But there is also a great snippet of Cuban being shocked - SHOCKED - hospitals still fear the cloud. We've also got details of nice panel at the Summit on Healthcare Price Cost and Quality Transparency in Washington, D.C., and brace yourself for a report out of MIT about the increases in cancer drugs since 1995. (Morning) Read on.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Billionaire tech investor Mark Cuban said healthcare entrepreneurs would be better off pursuing the direct-to-consumer market rather than trying to get their technology into hospitals. He views sensors and big data analytics as potential game changers in healthcare that will help physicians do a better job of understanding their patients needs beyond the range of […]
Cuban offered to buy a batch of CareAline’s products and brand them with the Dallas Mavericks’ logo. He will also make introductions to Dallas hospitals to get sales for CareAline. So what made CareAline so compelling Cuban couldn’t resist?
It’s not really surprising that our cell phones have 18 times more bacteria than a bathroom surface, when you really think about it. But do consumers really care to fix that? Two cousins from Provo, Utah pitched their product PhoneSoap, a sanitizer/charger for cell phones that uses UV light to clean phones, to the Shark […]
Health gadgets are stretching well beyond wrist-worn devices like the FitBit – electronic tattoos are rapidly becoming the wearable du jour. San Diego’s Electrozyme has developed a temporary tattoo that can gauge metabolic substances secreted in sweat – giving athletes a clue on their electrolyte balance, hydration level, muscle exertion and physical performance. “Every single wearable device on […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Billlionaire investor Mark Cuban, who owns the Dallas Mavericks and Landmark Theaters and is a regular on Shark Tank, has expanded his interests to personalized health. He is part of a group of investors in mobile health startup, Validic,which raised $760,000 in a seed round. The Durham, N.C., company has developed a platform to integrate […]
